Mobile fetal monitoring device from Cerner wins FDA nod

11/14/2012 | Kansas City Star (Mo.), The

The FDA has cleared Cerner to market its FetaLink+ fetal monitoring system. The technology is designed to allow clinicians to use their iPads or iPhones to access fetal and maternal data in near-real time and make informed medical decisions.

View Full Article in:

Kansas City Star (Mo.), The

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ
Chief Executive Officer
UCare Minnesota
Minneapolis, MN
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC